Xian-Hua-Cha for Relieving Hyperlipidemia With Obesity
Status:
Not yet recruiting
Trial end date:
2024-10-05
Target enrollment:
Participant gender:
Summary
In the past decades, lipid and body fat disorders become a serious global healthcare issue,
especially among the obese population. The aim of this study is to include 100 selected
patients with BMI higher than 27 and hyperlipidemia, and a crossover design is used to
explore the efficacy of "Xian-Hua-Cha (XHC)" on relieving hyperlipidemia among obese patient.
For this purpose, the changes of patients' body weight, body fat and the metabolic parameter
including blood sugar, cholesterol, triglyceride are analyzed in the end of this study.